382 related articles for article (PubMed ID: 29470609)
21. Anti-inflammatory therapies in atopic dermatitis.
Heratizadeh A; Werfel T
Allergy; 2016 Dec; 71(12):1666-1675. PubMed ID: 27735066
[TBL] [Abstract][Full Text] [Related]
22. Biological Therapies for Atopic Dermatitis: A Systematic Review.
Zhou S; Qi F; Gong Y; Zhang J; Zhu B
Dermatology; 2021; 237(4):542-552. PubMed ID: 33735876
[TBL] [Abstract][Full Text] [Related]
23. Dupilumab for off-label treatment of moderate to severe childhood atopic dermatitis.
Jorge E; Clark J
Cutis; 2018 Sep; 102(3):201-204. PubMed ID: 30372706
[TBL] [Abstract][Full Text] [Related]
24. Spotlight on dupilumab in the treatment of atopic dermatitis: design, development, and potential place in therapy.
D'Erme AM; Romanelli M; Chiricozzi A
Drug Des Devel Ther; 2017; 11():1473-1480. PubMed ID: 28553077
[TBL] [Abstract][Full Text] [Related]
25. Review of Systemic Treatment Options for Adult Atopic Dermatitis.
Gooderham M; Lynde CW; Papp K; Bourcier M; Guenther L; Gulliver W; Hong CH; Poulin Y; Sussman G; Vender R
J Cutan Med Surg; 2017; 21(1):31-39. PubMed ID: 27635033
[TBL] [Abstract][Full Text] [Related]
26. Dupilumab: A Review in Moderate-to-Severe Atopic Dermatitis.
Frampton JE; Blair HA
Am J Clin Dermatol; 2018 Aug; 19(4):617-624. PubMed ID: 30027349
[TBL] [Abstract][Full Text] [Related]
27. Systemic treatment of children and adolescents with atopic dermatitis aged ≥2 years: a Delphi consensus project mapping expert opinion in Northern Europe.
de Graaf M; Janmohamed SR; Schuttelaar MLA; Agner T; Alfonso JH; De Schepper S; Deleuran M; Despontin K; Elenius V; Ghislain PD; Huilaja L; Johansson EK; Kvenshagen BK; Mandelin JM; Olset H; Svensson A; van Tuyll van Serooskerken AM; Thyssen JP; Vestergaard C
J Eur Acad Dermatol Venereol; 2022 Nov; 36(11):2153-2165. PubMed ID: 35793471
[TBL] [Abstract][Full Text] [Related]
28. Biologic Therapy for Atopic Dermatitis: Moving Beyond the Practice Parameter and Guidelines.
Boguniewicz M
J Allergy Clin Immunol Pract; 2017; 5(6):1477-1487. PubMed ID: 29122151
[TBL] [Abstract][Full Text] [Related]
29. Assessing the New and Emerging Treatments for Atopic Dermatitis.
Eichenfield LF; Friedlander SF; Simpson EL; Irvine AD
Semin Cutan Med Surg; 2016 Jun; 35(5 Suppl):S92-6. PubMed ID: 27525671
[TBL] [Abstract][Full Text] [Related]
30. Novel Therapeutic Approaches and Targets for the Treatment of Atopic Dermatitis.
Pescitelli L; Rosi E; Ricceri F; Pimpinelli N; Prignano F
Curr Pharm Biotechnol; 2021; 22(1):73-84. PubMed ID: 32525769
[TBL] [Abstract][Full Text] [Related]
31. Nemolizumab for atopic dermatitis.
Labib A; Vander Does A; Yosipovitch G
Drugs Today (Barc); 2022 Apr; 58(4):159-173. PubMed ID: 35412530
[TBL] [Abstract][Full Text] [Related]
32. Dupilumab for treatment of atopic dermatitis.
Seegräber M; Srour J; Walter A; Knop M; Wollenberg A
Expert Rev Clin Pharmacol; 2018 May; 11(5):467-474. PubMed ID: 29557246
[TBL] [Abstract][Full Text] [Related]
33. [Pharmacological profiles and clinical findings of nemolizumab as treatment for pruritus associated with atopic dermatitis].
Kaneda N
Nihon Yakurigaku Zasshi; 2023; 158(3):282-289. PubMed ID: 37121713
[TBL] [Abstract][Full Text] [Related]
34. Adult atopic dermatitis: new and emerging therapies.
Napolitano M; Marasca C; Fabbrocini G; Patruno C
Expert Rev Clin Pharmacol; 2018 Sep; 11(9):867-878. PubMed ID: 30073901
[TBL] [Abstract][Full Text] [Related]
35. Dupilumab: human monoclonal antibody against IL-4Rα for moderate to severe atopic dermatitis.
Paton DM
Drugs Today (Barc); 2017 Sep; 53(9):477-487. PubMed ID: 29238761
[TBL] [Abstract][Full Text] [Related]
36. Efficacy and safety of systemic treatments for moderate-to-severe atopic dermatitis: a systematic review.
Roekevisch E; Spuls PI; Kuester D; Limpens J; Schmitt J
J Allergy Clin Immunol; 2014 Feb; 133(2):429-38. PubMed ID: 24269258
[TBL] [Abstract][Full Text] [Related]
37. Cyclosporine 0.1% (Ikervis
Roca-Ginés J; Rahhal-Ortuño M; Torres-Navarro I; Rodríguez-Serna M; Navarro-Mira MÁ
Arch Soc Esp Oftalmol (Engl Ed); 2019 Aug; 94(8):396-399. PubMed ID: 31178231
[TBL] [Abstract][Full Text] [Related]
38. Drug evaluation review: dupilumab in atopic dermatitis.
Hamilton JD; Ungar B; Guttman-Yassky E
Immunotherapy; 2015; 7(10):1043-58. PubMed ID: 26598956
[TBL] [Abstract][Full Text] [Related]
39. Off-label use of dupilumab for pediatric patients with atopic dermatitis: A multicenter retrospective review.
Igelman S; Kurta AO; Sheikh U; McWilliams A; Armbrecht E; Jackson Cullison SR; Kress DW; Smith A; Castelo-Soccio L; Treat J; Boothe WD; Diaz LZ; Levy ML; Patel A; Lee LW; Fraile-Alonso MC; Antaya RJ; Shah S; Kittler N; Arkin L; Siegfried E
J Am Acad Dermatol; 2020 Feb; 82(2):407-411. PubMed ID: 31606479
[TBL] [Abstract][Full Text] [Related]
40. Atopic dermatitis - Perspectives and unmet medical needs.
Buhl T; Werfel T
J Dtsch Dermatol Ges; 2023 Apr; 21(4):349-353. PubMed ID: 36960846
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
